"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super Bowl ad, leveling the accusation against brand-name weight loss drugs. Set ...

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...

Compounded drugs are custom-made medications by a licensed pharmacist or pharmacy technician. They alter ingredients, drug form, or dosage amounts to create a medication tailored to an individual’s ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...

Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and lucrative—tirzepatide drugs, namely knockoffs of Mounjaro for diabetes and ...

SILVER SPRING, Md. - Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as GLP-1s. The FDA says compounding pharmacies, ...

In an effort to prevent disease outbreaks similar to the cases of meningitis caused by the New England Compounding Center in October 2012, the Massachusetts House of Representatives unanimously voted ...

CDSCO introduces guidelines for compounding offences, streamlining compliance for pharma firms and minimizing court appearances for minor contraventions.